Roundtable Consultation on R&D Trends and Regulation for Biosimilars: Way Forward, New Delhi

The evolving biosimilars regulatory environment needs to be cognizant and sensitive to enable equitable access to low cost, safe and efficacious biosimilars-based biopharmaceuticals in the country. It was in this context, the Biotechnology Industry Research Assistance Council (BIRAC), Research Information System for Developing Countries (RIS) & Third World Network (TWN) held a roundtable to discuss […]